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ABSTRACT 
Ultrasound can be focused into deep tissues with millimeter precision to perform non-invasive ablative therapy for diseases such 
as cancer. In most cases, this ablation uses high intensity ultrasound to deposit non-selective thermal or mechanical energy at the 
ultrasound focus, damaging both healthy bystander tissue and cancer cells. Here we describe an alternative low intensity pulsed 
ultrasound approach that leverages the distinct mechanical properties of neoplastic cells to achieve inherent cancer selectivity.  
We show that when applied at a specific frequency and pulse duration, focused ultrasound selectively disrupts a panel of breast, 
colon, and leukemia cancer cell models in suspension without significantly damaging healthy immune or red blood cells. 
Mechanistic experiments reveal that the formation of acoustic standing waves and the emergence of cell-seeded cavitation lead 
to cytoskeletal disruption, expression of apoptotic markers, and cell death.  The inherent selectivity of this low intensity pulsed 
ultrasound approach offers a potentially safer and thus more broadly applicable alternative to non-selective high intensity 
ultrasound ablation. 
 
INTRODUCTION 
High intensity focused ultrasound (HIFU) is a non-invasive 
therapeutic modality used clinically for tumor ablation [1-5]. 
By producing local hyperthermia and destructive cavitation [6], 
HIFU induces cell lysis, increases chemotherapeutic uptake [4, 
7], and stimulates systemic anti-tumor immune responses [5, 
8].  However, high intensity (ISPTA >100 W/cm2) and high 
pressure (>10 MPa) focused ultrasound indiscriminately 
destroys healthy tissue as well as tumors [9, 10].  Consequently, 
safely implementing HIFU often requires costly MRI targeting 
[11] and is challenging in cancers near or invading into critical 
tissue [3].   
Several approaches aim to increase ultrasound’s 
specificity.  Molecularly targeted contrast agents, such as 
microbubbles [12, 13] locally amplify ultrasound’s disruptive 
effects, but are challenging to deploy in tumors due to the 
agents’ poor extravasation [14].  An alternative approach 
involves low intensity pulsed ultrasound (LIPUS).  Low 
intensity (ISPTA <5 W/cm2) and low frequency (<1 MHz) 
pulsed ultrasound produces mechanical effects without 
hyperthermia, resulting in neurostimulation [15], 
chemotherapy uptake [16], and bone repair [16-18].  However, 
its ability to selectively ablate cancer cells has not been studied, 
and its mechanisms of action are not fully understood [19-21]. 
Here we test the hypothesis that biomechanical 
differences between cancerous and healthy cell types cause 
these cells to have different responses to LIPUS, allowing 
selective ablation of cancer cells with targeted ultrasound 
waveforms. This hypothesis is predicated on cancer cells’ 
altered cellular/nuclear morphology, DNA content, nuclear-
nucleolar volume ratios, cytoskeletal stiffness, and viscoelastic 
properties [22-25]. In computational studies, these differences 
were predicted to result in the differential response of 
malignant cells to specific ultrasound parameters when 
compared to healthy cells [26]. We use a cell suspension model 
to test this experimentally and examine the underlying acoustic 
and biophysical mechanisms. 
 
RESULTS 
Tuning frequency and pulsing of LIPUS allows for 
cancer selective cytodisruption 
To test the hypothesis that LIPUS can selectively ablate cancer 
cells, we applied LIPUS to suspensions of human K562 and 
U937 cancer lines and primary T cells isolated from human 
peripheral blood mononuclear cells (PBMC), chosen as 
representative malignant and healthy cell types. Cell 
suspensions were placed in acoustically transparent-bottomed 
24-well plates and insonated with a focused ultrasound 
transducer positioned in a water bath below (Fig 1a).  We used 
pulsed ultrasound (10% duty cycle) with peak negative pressure 
(PNP) <1.2 MPa and ISPTA <5 W/cm2. We confirmed that 60 
seconds LIPUS at 0.67 MHz, 20ms pulse duration (PD) 
induced significant and irreversible cytodisruption of K562 
cells at PNP > 0.6 MPa, as measured with ethidium 
homodimer-1 (Ethd-1) uptake (Fig 1b).  Heating was always 
<1°C (Fig Sup 1).  For further experiments, we selected 0.7 
MPa PNP, which induced moderate cytodisruption. 
 To test different pulsing patterns, PD and pulse 
repetition frequency were varied simultaneously to maintain 
constant energy (Fig 1c).  We swept PD from 2-40ms with 
each of the 0.3, 0.5, and 0.67 MHz transducers (Fig 1d). We 
observed that cytodisruption was highly dependent on 
frequency, PD, and cell type. 20ms PD and 0.5 MHz 
maximized the selectivity with near complete cytodisruption 
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for K562 and U937 and >80% survival for T cells (Fig. 1e).  
We found that cytodisruption increases with longer PD, despite 
the same total energy applied.  Next, we assessed a broader 
panel of cell types at 0.5 MHz, using cancer cells in co-culture 
with PBMC (Table 1).  The cancer cell models showed 
significantly more cytodisruption than subpopulations within 
PBMC at >10ms PD.  (Fig 1f).  RBCs exhibited virtually no 
disruption, as measured by hemoglobin leakage, under any 
condition.  
 
LIPUS cytodisruption associated with cytoskeletal 
damage and activation of apoptotic, immunogenic 
cell death pathways 
To characterize LIPUS cytodisruption’s biomolecular 
mechanisms, we evaluated CT-26 cells 2 days after 2-minute 
treatment with 0.5 MHz, 0.7 MPa LIPUS with flow cytometry. 
At >10ms PD, increased cell death and apoptosis was observed 
[27] (Fig 2a).  Also, cells expressing calreticulin, a pro-
phagocytic signal [28], increased while proliferative marker 
Bcl-2 [29] decreased (Fig 2b). The activation of apoptotic and 
phagocytic pathways may enhance LIPUS’ effectiveness as an 
anti-cancer therapy by promoting anti-tumor immune 
response.  
To evaluate LIPUS’ effect on the cytoskeleton, we 
performed confocal microscopy on CT-26 immediately after 
LIPUS. The actin cytoskeleton, stained with phalloidin, is 
qualitatively and quantitatively disrupted after insonation with 
30ms PD LIPUS. This agrees with literature that states that 
LIPUS disrupts the cellular cytoskeleton [30, 31].  We 
demonstrate the novel property that at 1ms PD LIPUS, the 
cytoskeleton appears unchanged from the negative control 
(Fig 2c).  
 
Standing waves are necessary for LIPUS 
cytodisruption 
Next, we investigated the physical mechanisms transducing 
LIPUS into cellular effects. Literature suggests that acoustic 
standing waves affect the mechanical forces experienced by 
cells [32, 33].  Such waves can result from interference of an 
incident ultrasound wave with its reflection, forming a spatially 
static pattern of pressure nodes and anti-nodes.   
The pressure profile in acoustic 24-well plates 
revealed a standing wave pattern near the water-air interface. 
To examine whether this plays a role in cytodisruption, we 
constructed an acoustically transparent cuvette, where 
standing waves could be optionally introduced using a reflector 
(Fig 3a). We found that cells insonated in the absence of 
standing waves (0.67 MHz, 100ms PD) did not show significant 
cytodisruption, while cells treated in the presence of a reflector 
reproduced the cytodisruption observed in the 24-well plate 
(Fig 3b). Doubling the PNP in the reflector-free configuration 
to match the maximal pressure at standing wave anti-nodes did 
not induce significant cytodisruption. This suggests that 
standing waves are mechanistically required for LIPUS 
cytodisruption. 
Among other effects, acoustic pressure spatial 
gradients in standing waves give rise to acoustic radiation force 
that pushes cells toward pressure nodes [34]. We tracked the 
motion of fluorescently labeled K562 cells in response to 
continuous LIPUS in an imaging chamber and observed that 
0.5 MHz ultrasound in a standing wave configuration 
propelled cells toward the nodes (Fig. 3c). A 100ms PD was 
 
Figure 1 | Screening reveals ultrasound parameters that 
induce cancer-cell selective cytodisruption. a, Schematic of 
mylar-bottom 24-well plate over water bath containing focused 
ultrasound transducer.  b, K562 cell death (N=3, error bars 
SEM) in response to 0.67 MHz, 20ms PD, 10% duty cycle, 60 
seconds, LIPUS at various peak negative pressures (PNP). 0.7 
MPa PNP selected for future experiments.  c, Diagram 
depicting constant energy while sweeping PD.  d, 0.3 (N=4), 
0.5 (N=9), 0.67 (N=9) MHz LIPUS induces frequency-, PD-, 
and cell-dependent cytodisruption.  e, 0.5 MHz, 20ms PD 
LIPUS induces significantly less cell death (N=9, p<0.001) on 
T cells compared to either K562 or U937.   f, 0.5 MHz LIPUS 
induced cancer-selective cell death (N=9) in mixed sample of 
healthy PBMC and cancer models (Table 1), measured 
through cytometry. RBC death assessed using hemoglobin 
release.  Significance indicated as largest p-value from 2-tailed 
t-test between each cancer and each healthy cell model.  (* 
p<0.05, ** p<0.01, *** p<0.001).  
 
 
4T1 
Mouse Cell Line 
Mammary Gland, Epithelial 
(human breast cancer) 
CT26 Colon, Fibroblast (Carcinoma) 
MCF7 
Human Cell Line Mammary Gland, Epithelial (adenocarcinoma) SK-BR-3 
MDA-MB-231 
CD4 
Human Primary 
Cells, Peripheral 
Blood Cells 
CD3+, CD4+ 
CD8 CD3+, CD8+ 
B CD3-, CD19+ 
NK CD3-, CD19-, CD56+ 
RBC Bovine Primary Cells Peripheral Blood Cells 
Table 1 | Cell Models Tested at Targeted Parameters 
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not sufficient for cells to aggregate at nodes, which happened 
after ~1 second under continuous ultrasound. 
 
Cell-mediated cavitation is required for LIPUS 
cytodisruption 
Cavitation is a known mechanism for local amplification of 
acoustic pressure and cell killing [35]. To examine its role in 
LIPUS cytodisruption, we measured the acoustic emissions of 
cells treated with LIPUS in the acoustic cuvette using an 
orthogonally co-focused single-element passive cavitation 
detector (Fig 4a). We measured the signature of inertial 
cavitation (emissions with broad spectral content) and stable 
cavitation (harmonics of the transmitted frequency). As 
controls, we confirmed that no cavitation was measurable in 
degassed PBS cell buffer, while stable and inertial cavitation 
were detected from commercial Definity microbubbles (Fig. 
4b). 
K562 cells generated both stable and inertial 
cavitation when exposed to 0.5 MHz, 100ms PD LIPUS in the 
presence of a reflector.  The cavitation magnitude increased 
during the LIPUS pulse with an inflection point around 20ms 
(Fig 4b), a timescale similar to the PD needed for 
cytodisruption. No cavitation was seen without a reflector.  
Laser illumination of the cuvette revealed bubble formation in 
a standing wave pattern in response to long-PD ultrasound in 
the presence of the reflector (Fig 4d). 
The conditions resulting in LIPUS-induced 
cavitation in K562 cell suspensions correlate with those 
causing cytodisruption, with both requiring standing-waves 
and PD >20ms (Fig. 4c).  However, cavitation is not sufficient 
for cytodisruption, since PBMC, which are not strongly 
disrupted by tested LIPUS conditions, nevertheless produced 
similar amounts of cavitation (Fig 4c). 
To determine which components of cell suspensions 
could be responsible for cavitation, we measured acoustic 
signal from LIPUS-exposed solutions of cell-sized 10 μm 
polystyrene beads and liposomes. No cavitation was detected 
from the beads. However, degassed liposomes did produce 
cavitation, suggesting that cell’s lipid contents may have a role 
in promoting cavitation (Fig 4c).  
Finally, to confirm that cavitation is necessary for 
cytodisruption, we suppressed cavitation using over-pressure in 
an acoustically transparent pressure-chamber [36] comprising 
a plastic pipette bulb [37, 38] (Fig 4e).  With the bulb 
pressurized to 400 kPa above ambient pressure, there was an 
almost complete reduction of cytodisruption of K562 cells in 
the chamber by 100ms PD LIPUS.  This confirms that 
cavitation is mechanistically necessary. 
 
LIPUS results in translational motion of cells 
To visualize LIPUS’ effect on target cells, we imaged K562 
cells in suspension under transmitted laser illumination using 
an ultra-high speed camera.  Cells were floating between two 
acoustically transparent films near an acoustic reflector 
generating standing waves.  We recorded video at 5 Mfps 
starting 100ms after the beginning of insonation.  We observed 
cells translating several microns along the axis of insonation at 
the ultrasound frequency, but not undergoing large-scale 
deformation (Fig Sup 3, Sup Video).  This suggests that 
either that LIPUS’ effect on cell shape are on the nanoscale 
and thus not detectable in this imaging paradigm or involve 
deformation or displacement of sub-cellular organelles relative 
to the cytoplasm. 
 
LIPUS cytodisruption attenuated in solid media 
To investigate whether LIPUS cytodisruption occurs in cells 
embedded in solid media, we suspended K562 cells in agarose 
and acrylamide gels.  We placed these gels in our acoustic 
cuvette with the reflector to generate standing waves (Fig Sup 
4a).  Cell death was assessed using Ethd-1 fluorescence (Fig 
Sup 4b).  While statistically significant cytodisruption in 
agarose gels was observed, it was greatly attenuated compared 
to liquid suspensions (Fig Sup 4c).  This suggests that either 
the mechanical rigidity or the translational motion restriction 
 
Figure 2 | Ultrasound cytodisruption associated with 
apoptotic and pro-phagocytic pathways.  a, CT-26 cells 
assessed 2 days after LIPUS (0.5 MHz, 0.7 MPa 20ms PD, 
10% DC, 2 min).  Fraction of surviving cells and apoptotic cells 
assessed using flow cytometry Ethd-1 vs Annexin V graphs 
(Fig Sup 2).  X-axis from no ultrasound (∅) to 1-100ms PD.  
Significantly increased cell death and apoptosis with >10ms 
PD LIPUS (N=12, error bars SEM). b, Increase in pro-
phagocytic marker calreticulin (N=12) and decreased survival 
marker Bcl2 (N=8) but no change in proliferation marker Ki67 
(N=8) with >20ms PD US.  b, Confocal microscopy of CT-26 
cells immediately after LIPUS.  30 ms PD LIPUS disrupted 
actin ring and significantly decreased actin stain intensity 
(N=12). (** p<0.01, *** p<0.001). 
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imposed by a solid extra-cellular medium inhibits LIPUS cell 
killing. 
 
DISCUSSION 
Our results demonstrate that specific parameters of 
LIPUS can induce cancer cell-selective cytodisruption. In an in 
vitro model, LIPUS applied at 0.5 MHz with a 20ms PD had 
the largest therapeutic margin in disrupting a diverse panel of 
cancer cells while leaving healthy blood and immune cells 
largely intact. PD >10ms, the formation of standing waves, and 
the emergence of cavitation were necessary to disrupt cancer 
cells. However, the presence of cavitation, which was seeded 
by cells and enhanced by standing wave ARF, was not 
sufficient to guarantee the disruption of any particular cell type. 
This suggests that while cavitation may locally amplify the 
pressure supplied LIPUS, a given cell type’s response to the 
resulting mechanical stress depends on its biophysical 
properties. This is consistent with the “oncotripsy” theory 
developed by Ortiz et al [26, 39], which suggests that cells 
respond to ultrasound at different resonant frequencies and 
with different fatigue behavior [40, 41].  
Cancer-selective cytodisruption by LIPUS could 
fulfill the clinical need for safe non-invasive tumor ablation, 
complementing positional or molecular targeting approaches. 
Based on our results in suspension cell models, LIPUS applied 
within blood vessels could target blood cancer or circulating 
tumor cells [42]. The needed standing waves could be 
generated by engineering the acoustic field of one or more 
array sources or leveraging endogenous reflective surfaces such 
as bones. In addition, our data indicating that LIPUS-
disrupted cells show markers of apoptotic and immunogenic 
cell death (ICD) suggest that disruption of cancer cells in 
circulation could stimulate immune responses against solid 
tumors elsewhere and strengthen the effect of conventional 
chemotherapeutic regimens [43-51].  Additional work is 
needed to extend this technology into the solid tumor context. 
While in our experiments cells in hydrogel phantoms 
responded weakly to LIPUS, this biochemical and mechanical 
context may not accurately represent the solid tumor milieu. 
In addition, even partial killing of solid tumor cells could be 
effective if it can precipitate an abscopal immune effect.  Future 
in vivo studies are needed to test these hypotheses. 
 
MATERIALS AND METHODS 
High Throughput Ultrasound Experiments 
Acoustically transparent 2.5 μm mylar film (Chemplex #100) 
was placed on the bottom of 24-well no-bottom plates (Greiner 
Bio-One #662000-06) that have been painted with a thin film 
of Sylgard 184 PDMS (Fisher Scientific # NC9285739) and 
heat treated at 60 °C for 24 hours.  The resulting 24 well plates 
are watertight and have acoustically transparent bottoms.  The 
plates were sterilized and loaded with cell samples as required 
for ultrasound exposure. 
24 well plates were placed on a metal stage such that 
the mylar film was in contact with a water bath.  One of the 
three available FUS transducers (0.3 MHz: Benthowave BII-
7651/300, 0.5 MHz: Benthowave BII-7651/500, and 0.67 
MHz: Precision Acoustics PA717) was attached to a metal arm 
angled 20 degrees from the normal of the water bath.  A 
Velmex X-Slide motorized positioning system allowed the 3d 
motion of the arm allowing the transducers to be targeted at 
each well individually.  The transducers were aligned using a 
Precision Acoustics fiber optic hydrophone to target the 
bottom center of well A1 on the 24 well plate.  A MATLAB 
script controlled a signal generator (B&K #4054B) which 
generated a unique RF signal for each well of the plate and the 
Velmex positioning system.  This signal was then amplified 
(AR #100A250B) and sent to drive the FUS transducers.  The 
water bath was filled with distilled water which was degassed 
by a water conditioning system (ONDA #AQUAS-10) and 
heated to 37 degrees Celsius prior to experiments.  
 
Figure 3 | Standing waves required for LIPUS 
cytodisruptive effect.  a, Schematics of experimental setups 
with pressure field measurements.  Standing waves present in 
24-well plate, but not in acoustic cuvette unless a metal reflector 
is introduced.  b, 0.67 MHz, 100ms PD, 0.7 MPa LIPUS does 
not induce cell death in acoustic cuvette without reflector, even 
when doubling the pressure.  However, when the reflector is 
added, cell death occurs as observed previously.  c, 
Fluorescence microscopy demonstrates that cells accelerate 
toward nodes (N) in response to continuous 0.5 MHz, 0.7 MPa 
US.   Upper image is still frame after 5 seconds of ultrasound, 
lower image represents average of y dimension (perpendicular 
to US) versus time.  Cells achieve aggregation within 1 second. 
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Fiber optic thermometry was used to measure the 
effect of insonation at the highest frequency 0.67 MHz and 
highest pressure 1.2 MPa PNP tested to confirm that no 
heating would occur in LIPUS experiments.  Fiber was placed 
at ultrasound focus within acoustically transparent 24 well 
plate and temperature measurements were made for 1 ms and 
100 ms pulse duration insonations.  (Fig. Sup 1) 
For the parameter search experiments (Fig. 1d) 
K562, U-937, or T cells were spun down and carefully 
resuspended in vacuum degassed PBS containing 2 μM 
ethidium homodimer-1 (Ethd-1) at 2 million cells in 2 mL PBS 
in each well of an acoustic 24 well plate.  On each plate, 2 wells 
were loaded with 0.1% Triton X-100 as a positive control (pos) 
and 2 wells were un-insonated as a negative control (neg).  
Immediately after insonation, cell death for each well was 
estimated as Ethd-1 signal (s) as measured through plate reader 
as: cell death = (swell – sneg) / (spos – sneg). 
For the broad cell panel experiments (Fig. 1e), 2x106 
4T1, CT26, MCF7, SK-BR-3 or MDA-MB-231 cancer cells 
were mixed with 2x106 PBMCs in 2 mL degassed PBS 
respecitively and loaded into each well of an acoustic 24 well 
plate.  After insonation, 2x104 cells are cultured on 96 well 
plates for 2 days, and resuspended in PBS with 2 μM Ethd-1 
prior to analysis with flow cytometry.  For immune cell surface 
marker analysis, single-cell suspensions were stained with 
antibodies in PBS containing 2% fetal bovine serum. 
Antibodies to CD3(UCHT1), CD4(SK3), CD8(RPA-T8), 
CD19(SJ25-C1), CD33(P67.6) and CD56(5.1H11) were used 
to gate the CD4 T cells, CD8 T cells, B cells, myeloid cells and 
NK cells respecitively.  Myeloid cells, which are largely 
undifferentiated cells with similar mechanical properties as 
cancer cells and comprise <1% of the PBMC cells, were 
excluded from analysis.  Cell death for each subpopulation was 
determined from the count of cells that did not uptake Ethd-1 
in comparison to untreated control.   
Heparinized bovine red blood cells (Sierra for 
Medical Science), were diluted to 10% hematocrit in degassed 
PBS, then insonated as described above.  After ultrasound, 
RBCs were centrifuged so that samples of supernatant could 
be assessed for hemoglobin release (Abcam ab234046).  RBC 
death in resposne to LIPUS calculated as hemoglobin release 
compared to positive control 0.1% Triton X-100 and negative 
control of no ultrasound. (Fig. 1e) 
 
Biomolecular mechanism experiments 
For CT26 cell apoptosis and proliferation marker analysis,  2 
days after ultrasound treatment, CT26 cells were stained with 
anti-Calreticulin (Abcam) 30 min at room temperture. 
Annexin V binding buffer (Biolegend) was used for Annexin V 
staining. Fixation and permeabiliztion was performed with BD 
Cytofix/Cytoperm buffers (BD Biosciences) for Ki-67 and Bcl-
2 intracellular antibodies staining.  (Fig. 2a)  Cell death was 
determined from the count of cells that did not uptake Ethd-1 
in comparison to untreated control.  The percentage of 
apoptotic cells reported is the fraction of Annexin V positive 
and Ethd-1 negative cells measured through flow cytometry.  
Cell signaling pathway markers Bcl-2 and Ki-67 were the 
fraction of Bcl-2 or Ki-67 stain positive and Aqua (fixable dead 
cell stain) negative cells.  The pro-phagocytic marker 
calreticulin percentage reported was the fraction of calreticulin 
stain positive in all cells, live or dead. 
For confocal experiments, CT-26 cells were allowed 
to settle on PDL-coated 1.5 μm coverslips for 1 hour.  Slides 
 
Figure 4 | Cell-mediated cavitation is mechanistically 
necessary for cytodisruption.  a, Schematic of passive 
cavitation detection setup using 10 MHz transducer orthogonally 
positioned to FUS transducer.  b) Spectrogram of scattered 
signal from 100ms pulse of 0.5 MHz ultrasound transducer.  
Broadband signal of cavitation demonstrated with Definity 
positive control.  No cavitation in PBS, however cavitation 
present in K562 suspensions only with reflector. c) Cavitation 
energy (∫ P2 dt) partially correlates with cytodisruption.  
Significant cavitation (compared to “No US”, ** p<0.01, *** 
p<0.001) observed with Definity, with K562 / PBMC with 
reflector (RF) and >20ms PD, and with liposomes with RF and 
100ms PD. Note: PBMC cells induce cavitation, though they are 
resistant to LIPUS cyto-disruption.  d, 100ms PD LIPUS with 
reflector induces cavitation bubbles formed in standing wave 
pattern in K562 sample.  e, Schematic of pipet bulb pressurized 
to 400 kPa to form pressure chamber. At over-pressure, which 
suppresses cavitation, LIPUS cytodisruption is suppressed. 
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were treated with fixable LIVE/DEAD stain (ThermoFisher 
#L34971), fixed in 4% paraformaldehyde and stained with 
phalloidin (Cayman #20549).  Coverslips are then mounted 
with mountant containing DAPI (ThermoFisher #P36971).  
Four color confocal images were acquired with a 100x oil 
immersion objective at the Caltech Beckman Imaging Facility. 
(Fig 2b)  To quantify, the actin signal intensity was measured 
on 12 cells imaged in each ultrasound treatment condition. 
 
Standing Wave Experiments 
Pressure measurements performed using the fiber optic 
hydrophone positioned using the Velmex X-Slide.  Color scale 
pressure maps represent peak negative pressure at each 
position within well or acoustic cuvette.  Acoustic cuvettes were 
1 cm x 1 cm 3d printed chambers with walls made of mylar 
film fixed with super glue.  The cuvette was mounted to the 
bottom of the water tank and surrounded by distilled, degassed 
water.  The center of cuvettes were aligned with the FUS 
transducer focus using fiber optic hydrophone and Velmex 
positioning system.  A 3”x3”x0.5” rectangular prism block of 
aluminum was used as an acoustic reflector and positioned 
directly opposite from the transducer next to the cuvette (Fig 
3a).  K562 were loaded into the acoustic cuvette at 1 M cells 
/ mL containing 0.2 μM Ethd-1.  A 3d printed imaging 
chamber submersed in a water bath positioned the 0.5 MHz 
transducer a fixed position from an acoustic reflector, such that 
fluorescent imaging of a compartment containing GFP-labeled 
K562 at the focal point of the transducer could be achieved. 
Imaging was obtained through a 4x air objective (Olympus) 
(Fig. 3c).   
 
Cavitation Experiments 
Using the same setup for standing wave experiments, a 10 
MHz single element transducer (Olympus #U8421024) was 
positioned orthogonally to the FUS transducer, also aligned 
using the fiber optic hydrophone (Fig. 4a).  Samples were 
loaded into the acoustic cuvette.  Vacuum degassed PBS used 
as negative control.  10 μL of freshly resuspended Definity 
microbubbles (Lantheus Medical Imaging, Inc.) in degassed 
PBS used as positive control.  Aluminum reflector used as 
described above to introduce standing waves.  K562 or PBMC 
cells loaded at 1 M cells / mL in degassed PBS.  Liposomes 
were generated from 14.0-18.0 PC Avanti Polar lipid 
suspended in chloroform which was lyophilized to remove 
chloroform, rehydrated using degassed 300 mOsm sucrose 
solution, sonicated for 10 minutes, heated at 40°C for 10 
minutes, then degassed.  Liposomes solution resuspended in 
degassed PBS to approximate lipid concentration in cell 
samples.  10 μM polystyrene beads at 1 M beads / mL also 
measured.  Cavitation energy assessed in relative units by 
integrating the square of the pressure signal over time (Fig 4c).  
Image of cavitation bubbles taken using camera facing the 
single element transducer, with plane of laser illumination 
generated from laser light source and 1D diverging lens 
positioned above the acoustic cuvette (Fig 4d).  A pressure 
chamber was constructed by attaching a compressed air line 
with a gauge pressure of 400 kPa onto an acoustically 
transparent plastic pipet bulb.  Acoustic transmission through 
the pipet bulb was confirmed using hydrophone measurements.  
1 M/mL K-562 cells loaded in degassed PBS containing 2 μM 
Ethd-1 into the pipet bulb.  Cavitation from in samples loaded 
into the pipet bulb in place of the acoustic cuvette could be 
measured as described above.  Cell death assessed using Ethd-
1 signal (Fig 4e). 
 
Gel Experiments 
Agarose gels were prepared by mixing 2% agarose in vacuum-
degassed PBS at 65 °C with 2 M/mL K562 cells in PBS, 
adding 2 μM Ethd-1, and poured into 1 cm x 1 cm x 2.5 cm 
molds.  Acrylamide gels were prepared as in this reference [52] 
with a final concentration of 1 M/mL K562 and 2 μM Ethd-
1.  Gels were insonated in the acoustic cuvette as described 
above.  Cell death was calculated as magnitude of Ethd-1 
signal observed at LIPUS focus on gel reader in comparison to 
signal from gels injected with 0.1% Triton X-100 and gels not 
treated with LIPUS.   
 
High Speed Camera Experiments 
We assembled a high-speed microscopy setup capable of 
directly visualizing the effect of ultrasound on K562 cells. Our 
setup used a 2 W 532-nm laser (CNI, MLL-F532-2W) 
controlled by an optical beam shutter (Thorlabs SH05, 
KSC101). Right angle prism mirrors directed the laser light 
through a water bath and into a sample chamber containing 
the imaged samples. K562 cells were loaded into a custom-
made acrylic cartridge containing an inner pocket surrounded 
by mylar film.  A 3d printed holder positioned the cartridge 
such that the inner pocket was at the focus of the 0.5 MHz 
transducer.  The cells were freely floating between two 
acoustically transparent films near an acoustic reflector that 
generate standing waves.  A 100x water immersion Plan Fluor 
objective (Olympus) was used to image the target cells.  A series 
of prism mirrors and converging lenses with focal lengths of 
200 mm and 50 mm delivered the image into a Shimadzu 
HPV-X2 camera, which acquired 256 images over 51.2 µs, at 
a sampling rate of 5 million frames per second. To account for 
acoustic propagation through water, the camera was externally 
triggered to begin acquisition 100 ms after the start of the 
ultrasound pulse. A single pulse of 100 ms at 0.5 Mhz and 0.7 
MPa PNP was used to insonate the sample in these 
experiments. 
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